Infinitopes
Positioned to deliver revolutionary cancer vaccines
Oxford, United Kingdom · $35.1M raised
- Headquarters
- Oxford
- Employees
- 11–50
- Business Model
- B2B
- Website
- infinitopes.com
- Total Funding
- $35.1M
- Last Round
- $15.4M SeedJan 2025
- Rounds
- 2
About
Clinical-stage cancer vaccine biotech developing precision immunotherapies to prevent cancer recurrence using Precision Immunomics platform.
Summary
Infinitopes is a Biotech company based in Oxford, United Kingdom. It has raised $35.1M in total across 2 rounds, most recently a $15.4M Seed round in Jan 2025. Investors include octopus investments, Amplify Partners and Kindred Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png){kind=avatar}
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.